Source: US News & World Report
“The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research. Moderna’s vaccine is designed to target H5 and H7 avian influenza viruses. The company plans to move into phase 3 clinical trials to test the vaccine in a larger group of people after receiving positive results in earlier phases. It said those findings will be shared at an upcoming scientific conference.” (01/21/25)